// app/lymphocyte-immunization-therapy-in-noida/page.tsx
import type { Metadata } from "next";
import Link from "next/link";
import Image from "next/image";
import { TreatmentTemplate } from "@/components/page/TreatmentTemplate";

export const metadata: Metadata = {
  alternates: { canonical: "/lymphocyte-immunization-therapy-in-noida" },
  title: "LIT Treatment in Noida | Lymphocyte Immunization Therapy | Divine IVF",
  description:
    "Learn about Lymphocyte Immunization Therapy (LIT) in Noida for recurrent miscarriage and implantation concerns, including evidence, risks and fertility evaluation.",
  robots: { index: true, follow: true },
  keywords:
    "Lymphocyte Immunization Therapy in Noida, LIT Treatment in Noida, LIT Therapy in Noida, LIT Fertility Treatment in Noida, Lymphocyte Immunotherapy in Noida, Lymphocyte Immunization Treatment in Noida, Partner Lymphocyte Immunization, Paternal Lymphocyte Immunization, LIT for Recurrent Miscarriage, LIT for Recurrent Pregnancy Loss, LIT for Implantation Failure, LIT for Recurrent Implantation Failure, LIT for Failed IVF, Immune Treatment for Recurrent Miscarriage in Noida, Recurrent Miscarriage Treatment in Noida, Recurrent Pregnancy Loss Treatment in Noida, Recurrent Implantation Failure Treatment in Noida, IVF Failure Treatment in Noida, Reproductive Immunology Treatment in Noida, IVF Treatment in Noida, Fertility Investigation in Noida, Genetic Testing in IVF Noida, Fertility Clinic in Noida, Fertility Specialist in Noida, LIT Treatment Cost in Noida",
  openGraph: {
    title: "LIT Treatment in Noida | Lymphocyte Immunization Therapy | Divine IVF",
    description:
      "Understand Lymphocyte Immunization Therapy in Noida for recurrent pregnancy loss and implantation concerns, including current evidence, limitations and potential risks.",
    url: "https://www.divineivf.com/lymphocyte-immunization-therapy-in-noida",
    siteName: "Divine IVF",
    images: [
      {
        url: "https://plain-apac-prod-public.komododecks.com/202609/09/zn7ZNz1XRcQ9ZowBU1Ag/image.png",
        width: 1200,
        height: 630,
        alt: "Lymphocyte Immunization Therapy clinical procedure at Divine IVF, Noida",
      },
    ],
    locale: "en_IN",
    type: "website",
  },
};

export default function LitTherapyPage() {
  return (
    <TreatmentTemplate
      crumbs={[
        { label: "Home", href: "/" },
        { label: "Fertility Care", href: "/fertility" },
        { label: "Recurrent Pregnancy Loss", href: "/recurrent-pregnancy-loss" },
        { label: "LIT Treatment in Noida" },
      ]}
      eyebrow="Reproductive Immunology · Noida"
      // ========== H1 ==========
      titlePlain="Lymphocyte Immunization Therapy (LIT) in Noida"
      titleAccent="Understanding LIT as an experimental immune-related fertility treatment and when evidence-based fertility evaluation should come first"
      // =========================
      intro="If you have experienced recurrent pregnancy loss, repeated unsuccessful embryo transfers, or failed IVF treatment, you may have come across Lymphocyte Immunization Therapy (LIT) while researching fertility immunology treatments."
      heroImage="https://plain-apac-prod-public.komododecks.com/202609/09/zn7ZNz1XRcQ9ZowBU1Ag/image.png"
      heroAlt="Lymphocyte Immunization Therapy clinical procedure at Divine IVF, Noida"
      secondaryImage="https://images.unsplash.com/photo-1579154204845-15a696c8e6f4?q=80&w=1200&auto=format&fit=crop"
      secondaryImageAlt="Immunology laboratory work for Lymphocyte Immunization Therapy at Divine IVF Clinic, Noida"
      whatItIs={[
        "Lymphocyte Immunization Therapy, commonly called LIT, is an immune-based treatment that has been proposed for women experiencing recurrent pregnancy loss or implantation failure.",
        "The treatment involves obtaining lymphocytes, a type of white blood cell, usually from the male partner or another source according to the protocol being used. These lymphocytes are processed and then introduced into the female partner with the proposed intention of changing the maternal immune response.",
        "However, this proposed mechanism has not translated into sufficiently reliable evidence of improved live-birth outcomes. For this reason, LIT is not regarded as a standard fertility treatment.",
        "At Divine IVF, Sector 76, Noida, Dr. Mandavi Rai provides personalised fertility evaluation for recurrent pregnancy loss, implantation concerns and previous IVF failure. Lymphocyte Immunization Therapy is not considered a routine evidence-based fertility treatment. Major reproductive-medicine guidelines do not recommend its routine use for unexplained recurrent pregnancy loss because a meaningful clinical benefit has not been established and potential adverse effects exist.",
      ]}
      whoNeedsIt={[
        "Patients with recurrent pregnancy loss who have undergone a complete evidence-based evaluation",
        "Patients with recurrent implantation failure after comprehensive fertility assessment",
        "Patients with previous IVF failure where all recognised causes have been evaluated",
        "Patients who have been counselled about the experimental nature of LIT and its lack of proven benefit",
        "Patients who understand that LIT is not recommended by major reproductive guidelines",
        "Patients who have had all other recognised causes of pregnancy loss or implantation failure evaluated",
      ]}
      preparation={[
        "Before considering any experimental immune treatment, patients with recurrent miscarriage or failed implantation should receive a structured evaluation. This may include pregnancy history review, genetic assessment, uterine evaluation, antiphospholipid syndrome testing, thyroid and other medical condition assessment, and IVF and embryo history review.",
        "Patients should understand that LIT is not a routine evidence-based fertility treatment. Major reproductive-medicine guidelines do not recommend its routine use for unexplained recurrent pregnancy loss because a meaningful clinical benefit has not been established and potential adverse effects exist.",
        "Dr. Rai will review your complete fertility history, previous pregnancy losses, and any previous treatment outcomes before discussing whether any experimental therapy might be considered.",
      ]}
      howItWorks={[
        { title: "Step 1 – Blood Collection", description: "Blood may be collected from the male partner or another source according to the protocol." },
        { title: "Step 2 – Lymphocyte Separation", description: "White blood cells, including lymphocytes, are isolated from the blood sample." },
        { title: "Step 3 – Preparation", description: "The lymphocytes undergo laboratory preparation." },
        { title: "Step 4 – Administration", description: "Prepared lymphocytes may be introduced through injections into the female patient." },
        { title: "Step 5 – Repeat Treatment", description: "Some historical protocols have involved more than one treatment session. There is no universally accepted evidence-based fertility protocol because LIT is not a routine recommended therapy." },
      ]}
      whatToExpect="Patients considering LIT should first undergo a structured evaluation to identify recognised causes of pregnancy loss or failed implantation. If LIT is being considered, patients should receive clear counselling about the experimental nature of the treatment, the lack of proven benefit, and the potential risks. Dr. Rai will explain the specific reasoning and process for your case, since this therapy is only considered after individual evaluation and with full understanding of the limitations."
      benefits={[
        "Currently, there are no proven benefits of LIT for unexplained recurrent pregnancy loss or implantation failure that are supported by major reproductive-medicine guidelines.",
        "ESHRE specifically recommends that LIT should not be used as treatment for unexplained recurrent pregnancy loss because a significant beneficial effect has not been established and serious adverse effects may occur.",
        "Patients should be aware that LIT is not considered a standard evidence-based fertility treatment.",
      ]}
      considerations={[
        "It is not considered a standard evidence-based fertility treatment",
        "Major reproductive-medicine guidelines do not recommend its routine use for unexplained recurrent pregnancy loss",
        "A meaningful clinical benefit has not been established",
        "Potential adverse effects exist",
        "ESHRE recommends against its use due to lack of proven benefit and potential serious adverse effects",
        "Studies have produced inconsistent findings and have had methodological limitations",
        "There is no universally accepted evidence-based fertility protocol",
        "Patients should not be told that LIT is proven to increase pregnancy rates",
      ]}
      related={[
        { name: "Recurrent Pregnancy Loss", href: "/recurrent-pregnancy-loss", blurb: "Evaluation and treatment for recurrent pregnancy loss before considering experimental therapies." },
        { name: "Recurrent Implantation Failure", href: "/recurrent-implantation-failure", blurb: "Evaluation for repeated implantation failure before considering immune therapies." },
        { name: "IVF Treatment", href: "/ivf-treatment-in-noida", blurb: "The fertility treatment within which LIT has been proposed as an add-on." },
        { name: "Fertility Investigation", href: "/fertility-investigation-in-noida", blurb: "The comprehensive evaluation that should come before considering LIT." },
        { name: "Genetic Testing / PGT", href: "/genetic-testing-in-ivf-noida", blurb: "Genetic screening that may identify causes of recurrent pregnancy loss." },
        { name: "ERA Test", href: "/era-test-in-noida", blurb: "Endometrial receptivity testing for implantation concerns." },
        { name: "Intralipid Therapy", href: "/intralipid-therapy-in-noida", blurb: "Another immune-related fertility add-on with limited evidence." },
        { name: "Embryo Transfer", href: "/embryo-transfer", blurb: "The procedure for which LIT has been proposed as an add-on." },
        { name: "Dr. Mandavi Rai", href: "/doctor/dr-mandavi-rai", blurb: "Meet your fertility specialist at Divine IVF, Noida." },
      ]}
      externalResources={[
        {
          label: "Immunological Factors in Infertility",
          source: "ASRM · ReproductiveFacts.org",
          href: "https://www.reproductivefacts.org/news-and-publications/fact-sheets-and-infographics/immunological-factors-in-infertility/",
        },
        {
          label: "Federation of Obstetric & Gynaecological Societies of India",
          source: "FOGSI",
          href: "https://www.fogsi.org/",
        },
        {
          label: "Indian Society for Assisted Reproduction",
          source: "ISAR",
          href: "https://www.isarindia.com/",
        },
      ]}
      faqs={[
        {
          question: "What does LIT stand for?",
          answer:
            "LIT stands for Lymphocyte Immunization Therapy.",
        },
        {
          question: "What is LIT fertility treatment?",
          answer:
            "LIT is an immune-based therapy in which lymphocytes are prepared and administered with the proposed aim of modifying maternal immune responses.",
        },
        {
          question: "Is LIT used for recurrent miscarriage?",
          answer:
            "It has historically been proposed for recurrent miscarriage, but current major guidelines do not recommend it for unexplained recurrent pregnancy loss.",
        },
        {
          question: "Does LIT prevent miscarriage?",
          answer:
            "A reliable miscarriage-prevention benefit has not been established.",
        },
        {
          question: "Does LIT improve IVF success?",
          answer:
            "There is insufficient evidence to consider LIT a proven treatment for increasing IVF success or live birth.",
        },
        {
          question: "Is LIT recommended after failed embryo transfer?",
          answer:
            "No. Failed embryo transfer should first be evaluated for embryo, uterine, endometrial and other recognised fertility factors.",
        },
        {
          question: "Is LIT related to NK cells?",
          answer:
            "LIT has been discussed within reproductive-immunology approaches, but routine NK-cell testing and immune treatments are not supported by sufficient evidence.",
        },
        {
          question: "What are the risks of LIT?",
          answer:
            "Possible concerns include injection reactions, infection transmission, immune sensitisation and other adverse immune effects.",
        },
        {
          question: "Is LIT the same as intralipid therapy?",
          answer:
            "No. LIT involves lymphocytes, while intralipid therapy involves intravenous fat emulsion.",
        },
        {
          question: "Is LIT the same as IVIG?",
          answer:
            "No. IVIG contains immunoglobulins, while LIT involves lymphocyte immunisation.",
        },
        {
          question: "Do I need LIT after two miscarriages?",
          answer:
            "Not automatically. A structured recurrent pregnancy-loss assessment should be performed before considering experimental therapies.",
        },
        {
          question: "Can LIT guarantee a successful pregnancy?",
          answer:
            "No.",
        },
        {
          question: "What is the cost of LIT treatment in Noida?",
          answer:
            "Costs can vary, but patients should first establish whether there is a scientifically supported indication for treatment.",
        },
        {
          question: "Where can I get evaluated for recurrent miscarriage in Noida?",
          answer:
            "You can consult Dr. Mandavi Rai at Divine IVF, Sector 76, Noida for evaluation of recurrent pregnancy loss, IVF failure and related fertility concerns.",
        },
      ]}
    >
      {/* Rich Content with Images and Links */}
      <div className="space-y-6">
        {/* ========== H1 DISPLAYED PROMINENTLY ========== */}
        <h1 className="text-3xl md:text-4xl font-bold text-ink-900 tracking-tight">
          Lymphocyte Immunization Therapy (LIT) in Noida
        </h1>
        <p className="text-lg text-ink-600 -mt-2">
          Understanding LIT as an experimental immune-related fertility treatment and when evidence-based fertility evaluation should come first.
        </p>
        {/* ============================================= */}

        {/* Clinic Info & CTA */}
        <div className="bg-gradient-to-r from-rose-50/80 to-pink-50/50 rounded-2xl p-6 border border-rose-100/50 mb-8">
          <div className="flex flex-col md:flex-row md:items-center md:justify-between gap-4">
            <div>
              <p className="text-ink-600 text-sm">
                📍 Sector 76, Noida, Uttar Pradesh
              </p>
              <p className="text-ink-600 text-sm">
                📞 Call: <a href="tel:+917678451808" className="text-rose-600 font-semibold hover:underline">+91 7678451808</a>
              </p>
            </div>
            <Link
              href="/contact"
              className="bg-rose-600 text-white px-6 py-2.5 rounded-xl font-medium hover:bg-rose-700 transition-colors text-center whitespace-nowrap"
            >
              Book Recurrent Pregnancy Loss Consultation
            </Link>
          </div>
        </div>

        {/* Image Row 1 */}
        <div className="grid grid-cols-1 md:grid-cols-2 gap-6 my-8">
          <div className="relative rounded-xl overflow-hidden shadow-md aspect-[4/3]">
            <Image
              src="https://plain-apac-prod-public.komododecks.com/202608/29/r4FssgyOn1CDI8HHbnql/image.png"
              alt="Blood test for hormonal assessment during fertility evaluation at Divine IVF Noida"
              fill
              className="object-cover"
              sizes="(max-width: 768px) 100vw, 50vw"
            />
          </div>
          <div className="relative rounded-xl overflow-hidden shadow-md aspect-[4/3]">
            <Image
              src="https://plain-apac-prod-public.komododecks.com/202608/29/ihoqxAWpk2sngcSobHAv/image.png"
              alt="Ultrasound scan during fertility evaluation at Divine IVF Clinic in Sector 76 Noida"
              fill
              className="object-cover"
              sizes="(max-width: 768px) 100vw, 50vw"
            />
          </div>
        </div>

        {/* What Is Lymphocyte Immunization Therapy Section */}
        <div className="bg-white rounded-2xl p-6 border border-ink-100/50">
          <h2 className="text-xl font-bold text-ink-900 mb-4">What Is Lymphocyte Immunization Therapy?</h2>
          <p className="text-ink-600">
            <strong>Lymphocyte Immunization Therapy</strong>, commonly called <strong>LIT</strong>, is an immune-based treatment that has been proposed for women experiencing recurrent pregnancy loss or implantation failure.
          </p>
          <p className="text-ink-600 mt-2">
            The treatment involves obtaining <strong>lymphocytes</strong>, a type of white blood cell, usually from the male partner or another source according to the protocol being used.
          </p>
          <p className="text-ink-600 mt-2">
            These lymphocytes are processed and then introduced into the female partner with the proposed intention of changing the maternal immune response.
          </p>
          <p className="text-ink-600 mt-2 font-semibold">
            However, this proposed mechanism has not translated into sufficiently reliable evidence of improved live-birth outcomes. For this reason, LIT is not regarded as a standard fertility treatment.
          </p>
        </div>

        {/* What Does LIT Stand For / Why Has LIT Been Proposed */}
        <div className="bg-white rounded-2xl p-6 border border-ink-100/50">
          <h2 className="text-xl font-bold text-ink-900 mb-4">Understanding LIT</h2>
          
          <div className="space-y-4">
            <div>
              <h3 className="font-semibold text-ink-900">What Does LIT Stand For?</h3>
              <p className="text-ink-600 text-sm">LIT stands for Lymphocyte Immunization Therapy. You may also see related terms such as Lymphocyte Immunotherapy, Partner Lymphocyte Immunization, Paternal Lymphocyte Immunization, or Lymphocyte Immunization for Recurrent Miscarriage. These terms generally describe immune-modulating approaches involving lymphocytes.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900">Why Has LIT Been Proposed in Fertility Treatment?</h3>
              <p className="text-ink-600 text-sm">LIT was developed around theories that some miscarriages or implantation failures may involve an abnormal maternal immune response. The proposed idea was that exposure to lymphocytes from the male partner might help modify the woman`s immune response to pregnancy.</p>
              <p className="text-ink-600 text-sm mt-2">However, reproduction and maternal-fetal immune tolerance are complex. Current scientific evidence has not established LIT as an effective routine treatment for recurrent miscarriage.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900">Is LIT an IVF Treatment?</h3>
              <p className="text-ink-600 text-sm font-semibold">No.</p>
              <p className="text-ink-600 text-sm mt-1">LIT is not part of the standard IVF procedure. Standard IVF generally involves ovarian stimulation, egg retrieval, fertilisation, embryo culture, and embryo transfer. LIT has instead been proposed as an immune-related treatment add-on for selected patients with histories such as repeated pregnancy loss or unsuccessful embryo transfers. It should not be confused with IVF, ICSI, embryo transfer or genetic testing.</p>
            </div>
          </div>
        </div>

        {/* LIT for Recurrent Pregnancy Loss / What Is Recurrent Pregnancy Loss */}
        <div className="bg-rose-50/30 rounded-2xl p-6 border border-rose-100/50">
          <h2 className="text-lg font-bold text-ink-900 mb-3">LIT for Recurrent Pregnancy Loss</h2>
          <p className="text-ink-600 text-sm">Recurrent pregnancy loss can have many possible causes. These may include:</p>
          <div className="grid grid-cols-1 sm:grid-cols-2 gap-2 mt-3">
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Embryo chromosome abnormalities
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Parental chromosomal factors
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Uterine abnormalities
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Antiphospholipid syndrome
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Certain endocrine or medical conditions
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Maternal age
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Other recognised reproductive factors
            </div>
          </div>
          <p className="text-sm text-ink-500 mt-3">In some cases, no definite cause is identified. LIT has historically been proposed for unexplained recurrent pregnancy loss, but current major guidelines do not support its routine clinical use.</p>
          
          <h3 className="font-semibold text-ink-900 text-sm mt-4">What Is Recurrent Pregnancy Loss?</h3>
          <p className="text-ink-600 text-sm">Recurrent pregnancy loss generally refers to repeated spontaneous pregnancy losses. Modern clinical evaluation may begin after two pregnancy losses depending on the patient`s history and clinical circumstances. A structured evaluation can help identify potentially treatable causes before unproven immune therapies are considered.</p>
        </div>

        {/* LIT for Recurrent Implantation Failure / LIT After Failed IVF */}
        <div className="bg-white rounded-2xl p-6 border border-ink-100/50">
          <h2 className="text-xl font-bold text-ink-900 mb-4">LIT for Implantation Failure and Failed IVF</h2>
          
          <div className="space-y-4">
            <div>
              <h3 className="font-semibold text-ink-900">LIT for Recurrent Implantation Failure</h3>
              <p className="text-ink-600 text-sm">Some patients with repeated unsuccessful embryo transfers may search for immune therapies such as LIT. However, implantation failure may involve multiple factors. These include embryo chromosomal abnormalities, embryo quality, female age, uterine abnormalities, endometrial preparation, hydrosalpinx, transfer-related factors, male fertility factors, and other medical conditions.</p>
              <p className="text-ink-600 text-sm mt-2 font-semibold">LIT should not replace investigation of these recognised factors.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900">LIT After Failed IVF</h3>
              <p className="text-ink-600 text-sm">An unsuccessful IVF cycle does not automatically indicate an immune disorder. After failed IVF, the treatment cycle should be reviewed carefully.</p>
              <p className="text-ink-600 text-sm mt-2">Important areas include:</p>
              <div className="grid grid-cols-1 sm:grid-cols-2 gap-2 mt-2">
                <div className="flex items-start gap-2 text-sm text-ink-600">
                  <span className="text-rose-500">•</span>
                  Ovarian response
                </div>
                <div className="flex items-start gap-2 text-sm text-ink-600">
                  <span className="text-rose-500">•</span>
                  Number of mature eggs
                </div>
                <div className="flex items-start gap-2 text-sm text-ink-600">
                  <span className="text-rose-500">•</span>
                  Fertilisation
                </div>
                <div className="flex items-start gap-2 text-sm text-ink-600">
                  <span className="text-rose-500">•</span>
                  Embryo development
                </div>
                <div className="flex items-start gap-2 text-sm text-ink-600">
                  <span className="text-rose-500">•</span>
                  Blastocyst formation
                </div>
                <div className="flex items-start gap-2 text-sm text-ink-600">
                  <span className="text-rose-500">•</span>
                  Embryo transfer
                </div>
                <div className="flex items-start gap-2 text-sm text-ink-600">
                  <span className="text-rose-500">•</span>
                  Endometrial preparation
                </div>
                <div className="flex items-start gap-2 text-sm text-ink-600">
                  <span className="text-rose-500">•</span>
                  Female age
                </div>
                <div className="flex items-start gap-2 text-sm text-ink-600">
                  <span className="text-rose-500">•</span>
                  Sperm quality
                </div>
                <div className="flex items-start gap-2 text-sm text-ink-600">
                  <span className="text-rose-500">•</span>
                  Genetic factors
                </div>
              </div>
              <p className="text-sm text-ink-500 mt-2">Only after reviewing these factors should additional investigations be considered.</p>
            </div>
          </div>
        </div>

        {/* Image Row 2 */}
        <div className="grid grid-cols-1 md:grid-cols-3 gap-4 my-8">
          <div className="relative rounded-xl overflow-hidden shadow-md aspect-square">
            <Image
              src="https://plain-apac-prod-public.komododecks.com/202608/29/44zaH8kJRjOoRCqyCDM2/image.webp"
              alt="Lymphocyte preparation for LIT Therapy at Divine IVF Clinic Noida"
              fill
              className="object-cover"
              sizes="(max-width: 768px) 100vw, 33vw"
            />
          </div>
          <div className="relative rounded-xl overflow-hidden shadow-md aspect-square">
            <Image
              src="https://plain-apac-prod-public.komododecks.com/202609/08/CDBKdEp8rE4QX4kMEGcA/image.jpg"
              alt="LIT consultation with Dr. Mandavi Rai at Divine IVF Noida"
              fill
              className="object-cover"
              sizes="(max-width: 768px) 100vw, 33vw"
            />
          </div>
          <div className="relative rounded-xl overflow-hidden shadow-md aspect-square">
            <Image
              src="https://images.unsplash.com/photo-1631815589968-25f8a2c7aa92?q=80&w=1200&auto=format&fit=crop"
              alt="Immunological assessment for LIT Therapy at Divine IVF Noida"
              fill
              className="object-cover"
              sizes="(max-width: 768px) 100vw, 33vw"
            />
          </div>
        </div>

        {/* Does the Immune System Affect Pregnancy / Natural Killer Cells and LIT */}
        <div className="bg-white rounded-2xl p-6 border border-ink-100/50">
          <h2 className="text-xl font-bold text-ink-900 mb-4">The Immune System and Pregnancy</h2>
          
          <div className="space-y-4">
            <div>
              <h3 className="font-semibold text-ink-900">Does the Immune System Affect Pregnancy?</h3>
              <p className="text-ink-600 text-sm">Yes, the immune system plays an important role in pregnancy. However, this does not mean that immune abnormalities are the cause of every miscarriage or failed embryo transfer.</p>
              <p className="text-ink-600 text-sm mt-2">The maternal immune system interacts with the developing embryo, placental tissue, the endometrium, and various immune-cell populations. This relationship is complex and still an active area of research.</p>
              <p className="text-ink-600 text-sm mt-2 font-semibold">Therefore, broad immune treatments should not be assumed to improve fertility simply because the immune system is involved in pregnancy.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900">Natural Killer Cells and LIT</h3>
              <p className="text-ink-600 text-sm">Some fertility immunology approaches focus on Natural Killer (NK) cells. NK cells are normal immune cells and are naturally present within the uterus.</p>
              <p className="text-ink-600 text-sm mt-2">However:</p>
              <ul className="list-disc list-inside text-sm text-ink-600 mt-2 space-y-1">
                <li>Blood NK-cell measurements may not reflect uterine immune activity</li>
                <li>NK-cell testing lacks standardisation</li>
                <li>The relationship between NK-cell levels and pregnancy loss is not fully established</li>
                <li>An abnormal immune test does not automatically mean LIT is required</li>
              </ul>
              <p className="text-ink-600 text-sm mt-2 font-semibold">ASRM currently does not recommend routine immune testing and treatment in recurrent pregnancy loss.</p>
            </div>
          </div>
        </div>

        {/* How Has LIT Traditionally Been Performed */}
        <div className="bg-rose-50/30 rounded-2xl p-6 border border-rose-100/50">
          <h2 className="text-lg font-bold text-ink-900 mb-3">How Has LIT Traditionally Been Performed?</h2>
          <p className="text-ink-600 text-sm">Protocols vary and LIT is not standard fertility therapy.</p>
          <p className="text-ink-600 text-sm mt-2">Historically, treatment approaches have involved steps such as:</p>
          <ol className="list-decimal list-inside text-sm text-ink-600 mt-2 space-y-1">
            <li><strong>Blood Collection</strong> — Blood may be collected from the male partner or another source according to the protocol</li>
            <li><strong>Lymphocyte Separation</strong> — White blood cells, including lymphocytes, are isolated from the blood sample</li>
            <li><strong>Preparation</strong> — The lymphocytes undergo laboratory preparation</li>
            <li><strong>Administration</strong> — Prepared lymphocytes may be introduced through injections into the female patient</li>
            <li><strong>Repeat Treatment</strong> — Some historical protocols have involved more than one treatment session</li>
          </ol>
          <p className="text-sm text-ink-500 mt-3">There is no universally accepted evidence-based fertility protocol because LIT is not a routine recommended therapy.</p>
        </div>

        {/* Does LIT Improve Pregnancy Rate / Prevent Miscarriage / Improve IVF Success */}
        <div className="bg-white rounded-2xl p-6 border border-ink-100/50">
          <h2 className="text-xl font-bold text-ink-900 mb-4">Does LIT Improve Fertility Outcomes?</h2>
          
          <div className="space-y-4">
            <div>
              <h3 className="font-semibold text-ink-900">Does LIT Improve Pregnancy Rate?</h3>
              <p className="text-ink-600 text-sm font-semibold">Current evidence is insufficient to establish LIT as an effective way of improving pregnancy or live-birth outcomes in women with unexplained recurrent pregnancy loss.</p>
              <p className="text-ink-600 text-sm mt-2">Studies have produced inconsistent findings and have had methodological limitations. Therefore, patients should not be told that LIT is proven to increase pregnancy rates.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900">Does LIT Prevent Miscarriage?</h3>
              <p className="text-ink-600 text-sm font-semibold">There is currently no reliable evidence that LIT prevents miscarriage in women with unexplained recurrent pregnancy loss.</p>
              <p className="text-ink-600 text-sm mt-2">ESHRE specifically recommends that LIT should not be used as treatment for unexplained recurrent pregnancy loss because a significant beneficial effect has not been established and serious adverse effects may occur.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900">Does LIT Improve IVF Success?</h3>
              <p className="text-ink-600 text-sm">LIT has not been established as a proven method for improving IVF success. IVF outcome depends on multiple factors including female age, egg quality, sperm quality, embryo development, chromosomal status, uterine health, endometrial preparation, and underlying infertility diagnosis.</p>
              <p className="text-ink-600 text-sm mt-2 font-semibold">LIT cannot correct these factors.</p>
            </div>
          </div>
        </div>

        {/* Is LIT Recommended After Repeated Embryo Transfer Failure */}
        <div className="bg-white rounded-2xl p-6 border border-ink-100/50">
          <h2 className="text-xl font-bold text-ink-900 mb-4">Is LIT Recommended After Repeated Embryo Transfer Failure?</h2>
          <p className="text-ink-600 text-sm font-semibold">Routine LIT is not recommended simply because multiple embryo transfers have failed.</p>
          <p className="text-ink-600 text-sm mt-2">A structured evaluation should first review:</p>
          <div className="grid grid-cols-1 sm:grid-cols-2 gap-2 mt-3">
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Embryo factors
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Uterine cavity
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Endometrium
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Hydrosalpinx
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Transfer technique
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Genetic factors
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Female age
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Male fertility
            </div>
          </div>
          <p className="text-sm text-ink-500 mt-3">Optional or experimental treatments should only be considered after patients understand the uncertainty of benefit.</p>
        </div>

        {/* Risks and Possible Side Effects / Why Is LIT Controversial */}
        <div className="bg-rose-50/30 rounded-2xl p-6 border border-rose-100/50">
          <h2 className="text-lg font-bold text-ink-900 mb-3">Risks and Controversy of LIT</h2>
          
          <div className="space-y-4">
            <div>
              <h3 className="font-semibold text-ink-900 text-sm">Risks and Possible Side Effects of LIT</h3>
              <p className="text-ink-600 text-sm">LIT involves exposure to human immune cells and therefore has potential risks. Depending on the preparation and administration method, possible concerns can include injection-site reactions, pain, swelling, redness, fever or systemic reactions, allergic reactions, infection transmission risk, immune sensitisation, and other immunological complications.</p>
              <p className="text-ink-600 text-sm mt-2 font-semibold">ESHRE notes that there may be serious adverse effects and recommends against its use for unexplained recurrent pregnancy loss.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900 text-sm">Why Is LIT Controversial?</h3>
              <p className="text-ink-600 text-sm">LIT remains controversial because:</p>
              <ul className="list-disc list-inside text-sm text-ink-600 mt-2 space-y-1">
                <li>Its proposed immune mechanism is not fully established</li>
                <li>Studies have produced inconsistent results</li>
                <li>Clinical protocols are not standardised</li>
                <li>Immune testing methods vary</li>
                <li>Reliable live-birth benefit has not been demonstrated</li>
                <li>Potential adverse effects exist</li>
                <li>Major reproductive guidelines do not recommend routine use</li>
              </ul>
            </div>
          </div>
        </div>

        {/* LIT vs Intralipid Therapy / LIT vs IVIG */}
        <div className="bg-white rounded-2xl p-6 border border-ink-100/50">
          <h2 className="text-xl font-bold text-ink-900 mb-4">LIT vs Other Immune Therapies</h2>
          
          <div className="space-y-4">
            <div>
              <h3 className="font-semibold text-ink-900">LIT vs Intralipid Therapy</h3>
              <p className="text-ink-600 text-sm">Both LIT and <Link href="/intralipid-therapy-in-noida" className="text-rose-600 font-semibold hover:underline">intralipid therapy</Link> have been proposed as immune-related fertility treatments, but they are completely different. LIT uses prepared lymphocytes with the aim of modifying the maternal immune response. Intralipid therapy uses an intravenous lipid emulsion that has been proposed to influence immune activity. Neither treatment is established as a routine therapy for unexplained recurrent pregnancy loss.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900">LIT vs IVIG</h3>
              <p className="text-ink-600 text-sm">LIT uses lymphocytes for immune exposure. IVIG (Intravenous Immunoglobulin) is a blood-derived immunoglobulin preparation used for certain medical immune conditions. Neither should automatically be used as a fertility add-on for unexplained recurrent miscarriage.</p>
            </div>
          </div>
        </div>

        {/* What Should Be Checked Before Considering Immune Therapy */}
        <div className="bg-white rounded-2xl p-6 border border-ink-100/50">
          <h2 className="text-xl font-bold text-ink-900 mb-4">What Should Be Checked Before Considering Immune Therapy?</h2>
          <p className="text-ink-600 text-sm">Before considering any experimental immune treatment, patients with recurrent miscarriage or failed implantation should receive a structured evaluation.</p>
          
          <div className="space-y-3 mt-3">
            <div>
              <h3 className="font-semibold text-ink-900 text-sm">Pregnancy History</h3>
              <p className="text-ink-600 text-sm">The number, timing and nature of previous pregnancy losses are reviewed.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900 text-sm">Genetic Factors</h3>
              <p className="text-ink-600 text-sm">Genetic assessment may be appropriate depending on the clinical history. Testing pregnancy-loss tissue can also provide useful information in selected circumstances.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900 text-sm">Uterine Evaluation</h3>
              <p className="text-ink-600 text-sm">Assessment may help identify fibroids, polyps, uterine septum, adhesions, or other structural abnormalities.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900 text-sm">Antiphospholipid Syndrome</h3>
              <p className="text-ink-600 text-sm">Appropriate testing may be recommended when clinically indicated.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900 text-sm">Thyroid and Other Medical Conditions</h3>
              <p className="text-ink-600 text-sm">Relevant endocrine or systemic conditions should be assessed and managed appropriately.</p>
            </div>
            
            <div>
              <h3 className="font-semibold text-ink-900 text-sm">IVF and Embryo History</h3>
              <p className="text-ink-600 text-sm">For patients who have undergone IVF, previous embryo-development and transfer results should be reviewed.</p>
            </div>
          </div>
        </div>

        {/* What Treatments Are Used for Recurrent Pregnancy Loss / Is LIT Approved */}
        <div className="bg-rose-50/30 rounded-2xl p-6 border border-rose-100/50">
          <h2 className="text-lg font-bold text-ink-900 mb-3">What Treatments Are Used for Recurrent Pregnancy Loss?</h2>
          <p className="text-ink-600 text-sm">Treatment depends on the diagnosed cause. Examples can include:</p>
          <ul className="list-disc list-inside text-sm text-ink-600 mt-2 space-y-1">
            <li>Management of identified uterine abnormalities</li>
            <li>Treatment according to established protocols for antiphospholipid syndrome</li>
            <li>Management of thyroid or other medical conditions</li>
            <li>Genetic counselling when indicated</li>
            <li>IVF/PGT in selected genetic situations</li>
            <li>Appropriate pregnancy monitoring</li>
          </ul>
          <p className="text-sm text-ink-500 mt-2">When no cause is identified, patients should receive counselling about the uncertainty surrounding many empirical treatments.</p>
          
          <h3 className="font-semibold text-ink-900 text-sm mt-4">Is LIT Approved as Standard Fertility Treatment?</h3>
          <p className="text-ink-600 text-sm font-semibold">LIT is not considered a standard routine treatment supported by current major reproductive-medicine guidelines for unexplained recurrent pregnancy loss.</p>
          <p className="text-ink-600 text-sm mt-2">Patients should carefully evaluate claims made by any clinic offering it. Important questions include:</p>
          <ul className="list-disc list-inside text-sm text-ink-600 mt-2 space-y-1">
            <li>What guideline supports treatment?</li>
            <li>What evidence shows improved live birth?</li>
            <li>What risks are involved?</li>
            <li>Is the treatment being performed as part of a research protocol?</li>
            <li>What alternatives are available?</li>
          </ul>
        </div>

        {/* LIT Treatment Cost */}
        <div className="bg-white rounded-2xl p-6 border border-ink-100/50">
          <h2 className="text-xl font-bold text-ink-900 mb-4">Lymphocyte Immunization Therapy Cost in Noida</h2>
          <p className="text-ink-600 text-sm">The LIT treatment cost in Noida can vary depending on the provider, laboratory preparation, number of sessions and associated investigations.</p>
          <p className="text-ink-600 text-sm mt-2 font-semibold">However, cost should not be the first consideration.</p>
          <p className="text-ink-600 text-sm mt-2">Before paying for LIT, patients should ask:</p>
          <div className="grid grid-cols-1 sm:grid-cols-2 gap-2 mt-3">
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">✓</span>
              Why is it being recommended?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">✓</span>
              What evidence supports its use?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">✓</span>
              Is it part of a research protocol?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">✓</span>
              What are the potential risks?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">✓</span>
              Have established causes of miscarriage been evaluated?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">✓</span>
              What happens if treatment is not performed?
            </div>
          </div>
          <p className="text-sm text-ink-500 mt-3">Because LIT is not a routine guideline-supported therapy for unexplained recurrent pregnancy loss, patients should receive clear counselling before considering treatment.</p>
        </div>

        {/* Questions to Ask */}
        <div className="bg-rose-50/30 rounded-2xl p-6 border border-rose-100/50">
          <h3 className="text-sm font-semibold text-ink-900 mb-3 flex items-center gap-2">
            <span className="w-1.5 h-1.5 rounded-full bg-rose-500"></span>
            Questions to Ask Before LIT Treatment
          </h3>
          <p className="text-ink-600 text-sm">Before considering LIT, ask your fertility specialist:</p>
          <div className="grid grid-cols-1 sm:grid-cols-2 gap-2 mt-3">
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              What diagnosis is LIT intended to treat?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              What evidence supports LIT in my specific case?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Is it recommended by major fertility guidelines?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Have other causes of miscarriage been evaluated?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              What are the potential adverse effects?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Is donor or partner blood being used?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              What infection-screening procedures are followed?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              How many sessions are proposed?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Will the treatment improve live-birth rates?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              What evidence-based alternatives are available?
            </div>
            <div className="flex items-start gap-2 text-sm text-ink-600">
              <span className="text-rose-500">•</span>
              Is this treatment being offered as experimental therapy?
            </div>
          </div>
        </div>

        {/* Why Choose Divine IVF */}
        <div className="bg-white rounded-2xl p-6 border border-ink-100/50">
          <h2 className="text-xl font-bold text-ink-900 mb-4">Why Choose Divine IVF for Recurrent Pregnancy Loss Evaluation in Noida?</h2>
          <ul className="space-y-3">
            <li className="flex items-start gap-3 text-ink-600">
              <span className="text-rose-500 font-bold text-lg">✓</span>
              <div><strong className="text-ink-900">Structured Fertility Evaluation</strong> — Repeated pregnancy loss or implantation failure should first be investigated for recognised reproductive and medical causes.</div>
            </li>
            <li className="flex items-start gap-3 text-ink-600">
              <span className="text-rose-500 font-bold text-lg">✓</span>
              <div><strong className="text-ink-900">Review of Previous IVF Treatment</strong> — Previous embryo development, transfers and treatment protocols can be reviewed before additional therapy is considered.</div>
            </li>
            <li className="flex items-start gap-3 text-ink-600">
              <span className="text-rose-500 font-bold text-lg">✓</span>
              <div><strong className="text-ink-900">Genetic and Uterine Factors</strong> — Appropriate assessment for genetic, uterine and other fertility-related factors can be discussed.</div>
            </li>
            <li className="flex items-start gap-3 text-ink-600">
              <span className="text-rose-500 font-bold text-lg">✓</span>
              <div><strong className="text-ink-900">Evidence-Based Fertility Counselling</strong> — Patients should be informed when treatments have limited or uncertain supporting evidence.</div>
            </li>
            <li className="flex items-start gap-3 text-ink-600">
              <span className="text-rose-500 font-bold text-lg">✓</span>
              <div><strong className="text-ink-900">IVF and Advanced Fertility Care</strong> — Depending on the diagnosis, evidence-based fertility options such as IVF, ICSI, embryo transfer and genetic testing can be discussed when appropriate.</div>
            </li>
            <li className="flex items-start gap-3 text-ink-600">
              <span className="text-rose-500 font-bold text-lg">✓</span>
              <div><strong className="text-ink-900">Doctor-Led Fertility Care</strong> — Evaluation and fertility treatment planning are provided under the guidance of Dr. Mandavi Rai, Gynecologist &amp; IVF Specialist in Noida.</div>
            </li>
            <li className="flex items-start gap-3 text-ink-600">
              <span className="text-rose-500 font-bold text-lg">✓</span>
              <div><strong className="text-ink-900">Convenient Location in Sector 76, Noida</strong> — Divine IVF is located in Sector 76, Noida, for patients seeking fertility evaluation after miscarriage, implantation failure or previous unsuccessful IVF treatment.</div>
            </li>
          </ul>
        </div>

        {/* Closing CTA Section */}
        <div className="bg-gradient-to-br from-rose-600 to-rose-700 rounded-2xl p-8 text-white text-center mt-8">
          <h2 className="text-2xl font-bold mb-3">Book a Recurrent Pregnancy Loss Consultation in Noida</h2>
          <p className="text-rose-100 max-w-2xl mx-auto">
            If you have experienced repeated miscarriages, implantation failure or unsuccessful IVF treatment and are considering LIT or another immune therapy, begin with a detailed fertility evaluation.
            At Divine IVF, Sector 76, Noida, Dr. Mandavi Rai provides personalised assessment to identify recognised fertility, genetic, uterine and medical factors before discussing additional treatments.
          </p>
          <div className="mt-6 flex flex-col sm:flex-row gap-4 justify-center">
            <Link
              href="/contact"
              className="bg-white text-rose-600 px-8 py-3 rounded-xl font-semibold hover:bg-rose-50 transition-colors"
            >
              Book Recurrent Pregnancy Loss Consultation
            </Link>
            <a
              href="tel:+917678451808"
              className="bg-rose-500 text-white px-8 py-3 rounded-xl font-semibold hover:bg-rose-400 transition-colors border border-white/20"
            >
              Call +91 7678451808
            </a>
          </div>
          <p className="text-rose-200 text-sm mt-4">
            Divine IVF · Sector 76, Noida, Uttar Pradesh
          </p>
        </div>
      </div>
    </TreatmentTemplate>
  );
}